Effect of Erythromycin on Albendazole-Induced Teratogenicity in Pregnant Rats

Reza Ranjbar; Hossein  Najafzadeh; Hassan Morovvati; Mahmood  Khaksary Mahabady; elnaz lak

Zahedan Journal of Research in Medical Sciences

The Official Journal of Zahedan University of Medical Sciences

Current Issue All Issues In Press Articles Accepted Manuscripts Search

Journal Information Boards and Committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Contact Us Support Reviewer and AE Registration Form

APC

Authors Guide Submit Manuscript

Effect of Erythromycin on Albendazole-Induced Teratogenicity in Pregnant Rats

Author(s):

Reza Ranjbar¹,

Hossein Najafzadeh^2,*,

Hassan Morovvati³,

Mahmood Khaksary Mahabady¹,

elnaz lak⁴

1Department of Anatomy, Faculty of Veterinary Medicine, Shahid Chamram University, Ahwaz, Iran

2Department of Pharmacology, Faculty of Veterinary Medicine, Shahid Chamram University, Ahwaz, Iran

3Department of Histology, Faculty of Veterinary Medicine, Shahid Chamram University, Ahwaz, Iran

4Department of Basic Sciences, Faculty of Veterinary Medicine, Shahid Chamram University, Ahwaz,Iran

Zahedan Journal of Research in Medical Sciences:Vol. 15, issue 5; e92986

Published online:Nov 18, 2012

Article type:Research Article

Received:Jun 01, 2012

Accepted:Oct 24, 2012

How to Cite:Reza RanjbarHossein NajafzadehHassan Morovvati Mahmood Khaksary Mahabadyelnaz lakEffect of Erythromycin on Albendazole-Induced Teratogenicity in Pregnant Rats.Zahedan J Res Med Sci.15(5):e92986.

Abstract

Background: Albendazole is utilized as an anthelmentic agent. One its side effect is teratogenicity. This effect apparently is related to its metabolites especially albendazole sulfoxid. The aim of present study was evaluation effect of erythromycin (as enzyme inhibitor in biotransformation) on albendazole biotransformation and consequently fetal malformation.
Materials and Methods: Four groups of female pregnant wistar rats (8 rats each group) were used. First group received normal saline (as control group). A single oral dose 30 mg/kg of albendazole was administered to rats on day 10 of gestation in group 2. Rats in group 3 received albendazole similar group 2 and erythromycin at dose 60 mg/kg. Rats in group 4 received only erythromycin on day 10 of gestation. The rats were euthanatized on day 20 of gestation. The skeletal malformation of fetus was studied by stereomicroscope after staining by Alizarin red-Alcian blue
Results: The length and weight of fetuses were significantly decreased by albendazole but erythromycin did not prevent this effect. In group that received only erythromycin, the length and weight of fetuses was similar to control group. Erythromycin decreased albendazole effect on weight of placenta. There was an increase in resorption by erythromycin when co-administrated with albendazole. The incidence of skeletal malformations (mostly of the limbs, vertebrae and palate) decreased significantly by erythromycin when co-administrated with albendazole.
.
Conclusion: Thus, erythromycin may inhibit albendazole biotransformation and decrease teratogenicity of it metabolites; but this subject needs more detailed evaluation.

Keywords

Fulltext

The full text of this article is available on the PDF file.

References

1.
The References of this article are available on the PDF file.

comments